Status:
COMPLETED
Early Identification of Subclinical Atherosclerosis Using Non-Invasive Imaging Research (EISNER)
Lead Sponsor:
Cedars-Sinai Medical Center
Collaborating Sponsors:
The Eisner Foundation
Conditions:
Atherosclerosis
Coronary Artery Disease
Eligibility:
All Genders
45-80 years
Phase:
NA
Brief Summary
Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research (EISNER) is a multi-study research program being conducted at Cedars-Sinai Medical Center. The principal objective ...
Detailed Description
At baseline eligible subjects underwent a clinic visit where they were randomized 2:1 to a "scan group" which had complete cardiac risk assessment and CAC scanning or a "no scan group" which had only ...
Eligibility Criteria
Inclusion
- No symptoms of CAD
- Intermediate risk of CAD, defined as either:
- male with age of 55-80 years or female with age 65-80 years or
- male of 45-54 years and at least one CAD risk factor or female with age 55-64 years and at least one CAD risk factor
- Risk factors include: smoking, high blood pressure, high total or LDL cholesterol, low HDL cholesterol, diabetes, family history of early CAD.)
Exclusion
- History of CVD including heart attack, cardiomyopathy, peripheral artery disease, angina, revascularization, and CVA (stroke)
- Prior coronary calcium scan or coronary angiogram
- Pregnancy
- Required radiation badges for work (CSMC Radiation Safety ruling)
- Clinically unstable health status or significant medical co-morbidity
Key Trial Info
Start Date :
February 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
2137 Patients enrolled
Trial Details
Trial ID
NCT00927693
Start Date
February 1 2001
End Date
August 1 2010
Last Update
September 29 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cedars-Sinai Medical Center
Los Angeles, California, United States, 90048